Eloxx Pharmaceuticals Inc (ELOX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2010 | 12-2009 | 09-2009 | 06-2009 | 03-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,170 | -1,890 | -180 | -5,720 | -4,130 |
| Depreciation Amortization | 5,060 | 1,820 | 830 | 590 | 400 |
| Other Working Capital | 750 | 170 | -120 | -330 | -420 |
| Other Operating Activity | -740 | -1,670 | -1,570 | 1,500 | 1,150 |
| Operating Cash Flow | $-2,100 | $-1,570 | $-1,040 | $-3,960 | $-3,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1 | -1 | -1 | -4 | -4 |
| Other Investing Activity | 351 | 581 | 61 | -1,326 | -2,286 |
| Investing Cash Flow | $350 | $580 | $60 | $-1,330 | $-2,290 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 1,400 | 1,360 | 880 | 0 | 0 |
| Financing Cash Flow | $1,400 | $1,360 | $880 | $0 | $0 |
| Beginning Cash Position | 380 | 380 | 380 | 5,670 | 5,670 |
| End Cash Position | 40 | 750 | 270 | 380 | 370 |
| Net Cash Flow | $-340 | $370 | $-100 | $-5,290 | $-5,290 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,100 | -1,570 | -1,040 | -3,960 | -3,000 |
| Free Cash Flow | -2,100 | -1,570 | -1,040 | -3,960 | -3,000 |